Forte Biosciences, Inc. (FBRX)
76.99
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
Forte Biosciences Max Drawdown (5Y) : 99.82% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 99.82% |
| August 31, 2026 | 99.82% |
| July 31, 2026 | 99.82% |
| June 30, 2026 | 99.82% |
| May 31, 2026 | 99.82% |
| April 30, 2026 | 99.82% |
| March 31, 2026 | 99.82% |
| February 28, 2026 | 99.82% |
| January 31, 2026 | 99.82% |
| December 31, 2025 | 99.82% |
| November 30, 2025 | 99.82% |
| October 31, 2025 | 99.82% |
| September 30, 2025 | 99.82% |
| August 31, 2025 | 99.82% |
| July 31, 2025 | 99.82% |
| June 30, 2025 | 99.82% |
| May 31, 2025 | 99.82% |
| April 30, 2025 | 99.82% |
| March 31, 2025 | 99.82% |
| February 28, 2025 | 99.82% |
| January 31, 2025 | 99.82% |
| December 31, 2024 | 99.82% |
| November 30, 2024 | 99.82% |
| October 31, 2024 | 99.82% |
| September 30, 2024 | 99.82% |
| Date | Value |
|---|---|
| August 31, 2024 | 99.82% |
| July 31, 2024 | 99.82% |
| June 30, 2024 | 99.82% |
| May 31, 2024 | 99.82% |
| April 30, 2024 | 99.82% |
| March 31, 2024 | 99.82% |
| February 29, 2024 | 99.82% |
| January 31, 2024 | 99.82% |
| December 31, 2023 | 99.82% |
| November 30, 2023 | 99.82% |
| October 31, 2023 | 99.77% |
| September 30, 2023 | 99.73% |
| August 31, 2023 | 99.65% |
| July 31, 2023 | 99.59% |
| June 30, 2023 | 99.59% |
| May 31, 2023 | 99.59% |
| April 30, 2023 | 99.59% |
| March 31, 2023 | 99.59% |
| February 28, 2023 | 99.59% |
| January 31, 2023 | 99.59% |
| December 31, 2022 | 99.59% |
| November 30, 2022 | 99.59% |
| October 31, 2022 | 99.57% |
| September 30, 2022 | 99.57% |
| August 31, 2022 | 99.57% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| argenx SE | 38.20% |
| ACADIA Pharmaceuticals, Inc. | 77.18% |
| Alnylam Pharmaceuticals, Inc. | 58.17% |
| Savara, Inc. | 93.79% |
| Vericel Corp. | 73.97% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -25.32 |
| Beta (5Y) | 2.232 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 197.6% |
| Historical Sharpe Ratio (5Y) | -0.0151 |
| Historical Sortino (5Y) | -0.0689 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 35.39% |